Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of human interferon alpha-2b spray for pediatric herpangina
CTR20222798Phase 2Completed
- Sponsor
- Anke Bio
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Anterferon in herpangina, sponsored by Anke Bio. Started May 2024; status: completed.
02
Drugs
Anterferon
03
Conditions
herpangina
Beyond the preview
Go deeper on CTR20222798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222798.